IDEXX Soars 20.2% on Earnings Beat: What It Means for Your S&P 500 Index Fund

IDEXX Soars 20.2% on Earnings Beat: What It Means for Your S&P 500 Index Fund

IDEXX Laboratories exploded higher on Monday, and millions of retirement savers felt it without ever picking the stock. How much it moved your 401(k) depends on a kind of hidden overlap most investors never think to check.

IDEXX raises forecast, betting diagnostics can offset weak vet visits - Regional Media News

By Sahil Pandey Nov 2 (Reuters) - IDEXX Laboratories beat quarterly estimates and raised its annual profit and revenue forecast on Monday, betting that rising diagnostic use per visit and new product launches will sustain growth through softer veterinary clinic traffic. Shares of the pet diagnostics maker climbed more than 19% in morning trading. The results come as animal-health companies continue to monitor softer pet owner spending and fewer …

IDEXX outlines 2026 revenue of $4.741B-$4.767B and EPS of $14.96-$15.16 as CoVet adds about $5M (NASDAQ:IDXX)

IDEXX Q3 2026 earnings: raised revenue and EPS outlook, strong diagnostics growth, and CoVet AI expansion.

IDEXX (IDXX) Q3 2026 Earnings Call Transcript

Diagnostics revenue surged 11% as premium instrument placements expanded globally.

Pet-Health Name Barks Up A Beat, And Fetches A Bullish Move

Idexx Laboratories outperformed a shaky macro on Monday, beating third-quarter forecasts. Idexx stock surged.

IDEXX Laboratories (NASDAQ:IDXX) Issues FY 2026 Earnings Guidance

IDEXX Laboratories (NASDAQ:IDXX – Get Free Report) updated its FY 2026 earnings guidance on Tuesday morning. The company provided earnings per share guidance of 14.960-15.160 for the period, compared to the consensus EPS estimate of 14.860. The company issued revenue guidance of $4.7 billion-$4.8 billion, compared to the consensus revenue estimate of $4.7 billion. Analysts […]